Daily problems involving contact with patients with terminal renal failure

被引:2
作者
Moeller, M. J. [1 ]
Heidenreich, S. [2 ]
Gladziwa, U. [3 ]
Floege, J. [1 ]
机构
[1] Rhein Westfal TH Aachen, Univ Klinikum, Med Klin 2, Pauwelsstr 30, D-52057 Aachen, Germany
[2] KfH Dialysezentrum, Aachen, Germany
[3] KfH Dialysezentrum, Wurselen, Germany
来源
INTERNIST | 2007年 / 48卷 / 08期
关键词
Dialysis patient; Chronic kidney disease; Renal transplantation; Cardiovascular events; Infections;
D O I
10.1007/s00108-007-1888-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Practitioners and physicians working in emergency rooms are often confronted with dialysis patients or patients who have received a kidney transplant. For dialysis patients, the mode of dialysis treatment needs to be assessed and dialysis access should be secured. Furthermore, the indications for the next dialysis treatment need to be determined. Dialysis patients often present themselves because of fluid overload, hypo- or hypertensive episodes, electrolyte disturbances, fever or cardiovascular events. Patients undergoing continous peritoneal dialysis are at an increased risk of infection of the catheter or of peritonitis. Patients with a renal transplant require continuation of their immunosuppression and the function of the transplant should be monitored. These patients often present with infections in which case the degree of immunosuppression may need to be reduced. Vaccinations as well as an increased risk for malignancies require special attention in these patients.
引用
收藏
页码:795 / 803
页数:9
相关论文
共 12 条
[1]  
Allon M, 2004, AM J KIDNEY DIS, V44, P779, DOI 10.1016/S0272-6386(04)01078-9
[2]   The use of vaccines in adult patients with renal disease [J].
Dinits-Pensy, M ;
Forrest, GN ;
Cross, AS ;
Hise, MK .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2005, 46 (06) :997-1011
[3]   Infection in organ-transplant recipients [J].
Fishman, JA ;
Rubin, RH .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (24) :1741-1751
[4]  
Keane WF, 2000, PERITON DIALYSIS INT, V20, P396
[5]   B-type natriuretic peptide for acute dyspnea in patients with kidney disease: Insights from a randomized comparison [J].
Mueller, C ;
Laule-Kilian, K ;
Scholer, A ;
Nusbaumer, C ;
Zeller, T ;
Staub, D ;
Perruchoud, AP .
KIDNEY INTERNATIONAL, 2005, 67 (01) :278-284
[6]   Treatment of acute coronary syndromes in patients who have chronic kidney disease [J].
O'Hanlon, R ;
Reddan, DN .
MEDICAL CLINICS OF NORTH AMERICA, 2005, 89 (03) :563-+
[7]  
Pham P-TT, 2007, COMPREHENSIVE CLIN N
[8]   Dosing considerations and monitoring of low molecular weight heparins and glycoprotein IIb/IIIa antagonists in patients with renal insufficiency [J].
Chidambaram Rammohan ;
Dan Fintel .
Current Cardiology Reports, 2003, 5 (4) :303-309
[9]   Subcutaneous terbutaline use in CKD to reduce potassium concentrations [J].
Sowinski, KM ;
Cronin, D ;
Mueller, BA ;
Kraus, MA .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2005, 45 (06) :1040-1045
[10]   Care of the end-stage renal disease patient on dialysis in the ED [J].
Venkat, Arvind ;
Kaufmann, Kristiana R. ;
Venkat, K. K. .
AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2006, 24 (07) :847-858